Pharma VC Funds

Digitalis Ventures is a venture capital firm established in 2016, focused on investing in innovative solutions within the realms of human and animal health. Headquartered in New York, with offices in Boston, Los Angeles, San Diego, San Francisco, and Gainesville, the firm leverages deep technical, financial, and domain expertise to support early-stage companies. Digitalis Ventures’ portfolio includes companies like Expressable, Elegen, and Alterome Therapeutics, reflecting their interest in biotechnology, health technologies, and services. Notable exits include Scout Bio and PetMedix. The firm typically leads investment rounds, providing substantial capital and strategic guidance to help startups scale. The investment strategy centers around life sciences, health technologies, and animal health. They invest in companies developing breakthrough technologies in therapeutics, diagnostics, and tools that improve healthcare access, outcomes, and efficiency. Their Companion Fund specifically focuses on advancing animal health. Key team members include founder Geoffrey Smith and partners such as Amit Bansal and Drew Taylor, who bring extensive experience in venture investing and health technologies.

firm focuses on investing in early-stage companies within the digital health sector, aiming to address significant challenges and inefficiencies in healthcare. Their investment strategy centers on data-driven technologies that can revolutionize healthcare and improve patient outcomes through innovative solutions in personalized medicine, data analytics, and digital therapeutics. DigiTx Partners is notable for backing companies like Eko, which develops diagnostic devices for heart and lung diseases, and Rune Labs, which focuses on precision neurology through software and data analytics. Their portfolio also includes Cleerly, specializing in cardiovascular disease diagnostics, and Savonix, which offers cognitive function management systems. The firm was created as a joint venture between Astellas Pharma and MPM Capital, and it raised $75 million for its Rx Digital Fund in 2018. This fund supports seed and Series A-stage companies that are developing healthcare and life sciences technology utilizing data​. Key team members include Managing Director David Kim, MD, and Partner & Principal Miraj Sanghvi, who bring substantial expertise in healthcare and investment management.

Dimension Capital is an early-stage venture capital firm founded in 2022 by industry veterans from Lux Capital and Obvious Ventures. With a focus on the intersection of biotechnology, life sciences, and technology, the firm operates a $350 million fund aimed at digitizing the biotech sector. Their mission is to break down the traditional silos separating technology and life sciences, creating new synergies between fields like drug discovery and artificial intelligence. Dimension invests in startups that leverage technology to drive advancements in biotech, such as Enveda Biosciences and Kaleidoscope Bio. The firm targets transformative companies in sectors including AI-driven drug discovery, machine learning applications in healthcare, and advanced manufacturing. Led by Adam Goulburn, Zavain Dar, and Nan Li, Dimension emphasizes long-term partnerships with founders, providing both capital and strategic guidance. They are particularly interested in companies at the forefront of merging biology with computational technologies, a space they believe is critical to the future of medicine​. Based in New York and San Francisco, Dimension is well-positioned in two key innovation hubs, giving it access to cutting-edge talent and startups that are redefining the biotech landscape​.

Distributed Ventures is a venture capital firm that focuses on investing in startups transforming the future of risk management across sectors like Insurtech, Fintech, and Health & Benefits. Originally incubated within NFP Ventures, the firm spun out as an independent entity in 2021 to focus on supporting early-stage companies. Distributed Ventures typically invests in late seed and Series A rounds, with a strong emphasis on businesses that drive innovation in their respective fields. The firm’s investment approach is rooted in its deep industry expertise, combining financial backing with strategic guidance to help portfolio companies scale efficiently. Distributed Ventures is particularly known for its hands-on involvement, offering operational support through its team of experienced investors and operators. The firm’s portfolio includes a diverse array of startups, such as those improving healthcare delivery, enhancing financial services, and innovating within the insurance industry. This focus on sectors at the intersection of technology and risk management reflects Distributed Ventures' commitment to shaping the future of these critical industries. The firm is led by a seasoned team, including Managing Partner Shawn Ellis, who has a strong background in venture capital and corporate innovation. Distributed Ventures is also notable for its strategic partnerships, which enable the firm to provide more than just capital to its portfolio companies, helping them navigate complex regulatory landscapes and scale their operations effectively​.

Divergent Capital is a New York-based venture capital firm founded in 2020 by Katie Shea and Lucy Wang. The fund focuses on pre-seed investments, typically writing checks between $250,000 and $750,000. Divergent Capital aims to back 20-25 companies, emphasizing high-conviction investments with deep engagement in sectors like AI, machine learning, robotics, biotech, logistics, and digital health. The firm is known for investing in founders with innovative technologies and unique customer insights, often those outside the traditional Silicon Valley circles. Divergent takes a hands-on approach with its portfolio companies, offering strategic guidance on product development, go-to-market strategies, and scaling. They prefer working with founders who have a deep personal connection to the problem they are solving, focusing on practical, product-driven growth rather than market size alone. Notable investments include companies like Hoop, Motif Neurotech, and Ceragen, spanning industries from productivity software to biotechnology.

DNS Capital is the investment office for Gigi Pritzker and her husband Michael Pucker, based in Chicago. Founded in 2014, DNS Capital invests across various stages and industries, emphasizing long-term partnerships and strategic growth. The firm has a diverse portfolio with significant investments in technology, healthcare, and industrial sectors. Notable investments include Hero Bread, which focuses on producing low-carb bakery products; IMIDomics, a biotech company working on therapeutics for immune-mediated inflammatory diseases; and Jetti Resources, which has developed a novel technology for metal extraction from ores. Other key investments include Recogni, a company specializing in high-performance computer chips for autonomous vehicles, and PayNearMe, a platform enhancing payment experiences for businesses and their customers​​. DNS Capital's approach combines financial support with strategic guidance, leveraging the deep expertise of its leadership team. They focus on building strong relationships with business owners and management teams to drive sustainable growth and innovation across their portfolio companies​.

Dolby Family Ventures is a San Francisco-based venture capital firm founded in 2014 by David Dolby, investing in early-stage companies tackling frontier science and engineering challenges. Unaffiliated with Dolby Laboratories, the firm manages approximately $196 million in assets under management. The 16-person team is led by David Dolby as CEO, Senior Managing Director Pascal Levensohn, and Managing Director Andrew Krowne, supported by a distinguished Scientific Advisory Board. With 106 investments and a strong exit track record of 6 IPOs and 17 acquisitions, Dolby Family Ventures leads rounds across pre-seed, seed, and Series A with checks from $1 million to $25 million. The five core verticals are precision neuroscience (neurodegeneration, psychiatry, neurotech), life sciences platforms (regenerative medicine, computational biology), climate tech, aerospace, and digital deep tech. Portfolio companies include Motif Neurotech, Therini Bio, Ursa Major Technologies, Twelve, Paradromics, Bionaut Labs, and DigiLens. IPO exits include Athira Pharma, Eargo, Cognition Therapeutics, and Tempo Automation; acquisition exits include August (by Assa Abloy), Wickr (by Amazon), and Eyefluence (by Google). The firm takes a long-term collaborative approach, partnering with best-in-class innovators and syndicate partners to build transformative technology companies. Its willingness to back science-forward ventures at the earliest stages — often where commercial validation is years away — and the depth of the Scientific Advisory Board distinguish DFV from generalist firms operating across the same broad technology sectors.

Domain Capital Group, founded in 1985, specializes in biotechnology investments, managing a substantial $2.8 billion in assets. They have funded 194 companies in the biopharma, medical device, and diagnostic sectors, resulting in 90 IPOs and 110 M&A events. Notable companies in their portfolio include Zipline, GitLab, and DigitalOcean. Domain Capital’s strategy focuses on long-term partnerships and a diversified asset approach, investing in real estate, natural resources, media, entertainment, technology, and special situations to achieve stable, cash-on-cash returns. They operate globally with a team led by seasoned partners like James Blair and Brian Halak. Their investment process involves rigorous due diligence, strategic transaction structuring, and active asset management to ensure value creation and capital preservation. Domain Capital typically engages in growth and late-stage investments, leveraging their extensive industry experience and strong relationships to source and manage deals effectively. The firm’s hands-on approach includes personalized investor engagement, aiming to meet specific investment goals such as targeted returns and risk mitigation. This comprehensive strategy positions Domain Capital as a trusted partner for public and private pension plans, corporations, foundations, endowments, and high-net-worth individuals.

Dorm Room Fund (DRF), founded in 2012 by Josh Kopelman under the auspices of First Round Capital, is a venture capital firm that focuses on investing in student-run startups. Headquartered in Cambridge, Massachusetts, DRF has made over 400 investments and has achieved 145 exits. Notable exits include MetaMap, DiscreetAI, WorkerSense, and ScienceIO. DRF’s mission is to support student founders by providing access to a powerful investor network, world-class mentors, and essential capital to accelerate their growth. The fund has supported over 300 companies led by student founders, including prominent names like Athelas and WellTheory. Dorm Room Fund is dedicated to promoting diversity, equity, and inclusion within the venture capital industry. Nearly 80% of their alumni go on to become founders or venture capitalists themselves. The fund has created initiatives like the Blueprint Project and the Female Founder Track to empower underrepresented students. The investment team at DRF consists of student partners who bring unique insights into the next wave of groundbreaking companies. This model allows them to identify promising startups that might be overlooked by traditional investors.

Dow Venture Capital, a corporate venture arm of Dow Inc., focuses on strategic investments that align with Dow's broader goals of sustainability and innovation. Established in 1994, the unit is headquartered in Midland, Michigan, and targets a range of sectors including clean technology, advanced materials, recycling, and healthcare. Their investments often seek to advance circular economy solutions, such as their partnerships with companies like Plastogaz, which aims to simplify plastic recycling processes through advanced catalytic technology, and Mura Technology, which focuses on chemical recycling for hard-to-recycle plastics. Dow Venture Capital also collaborates with companies in the fields of renewable energy, water treatment, and sustainable agriculture, demonstrating their commitment to tackling global environmental challenges. With a presence across North America, Europe, and Asia, their approach blends Dow’s extensive materials science expertise with innovative startup technologies, facilitating solutions that can scale globally. Dow's focus on recycling has led to investments that aim to close the loop on plastic waste, ensuring materials can be reused sustainably​. Overall, Dow Venture Capital plays a key role in Dow’s strategic direction by supporting startups that drive growth and value, particularly in areas that complement their sustainability mission and core business sectors.

Downing LLP is a UK-based investment management firm that emphasizes sustainable and impactful investments across various sectors. Established in 1986, Downing manages around £2 billion in assets, offering a diverse range of investment strategies. It has built a reputation for responsible investing, holding a B Corp certification, which underscores its commitment to balancing profit with social and environmental responsibility. Downing Ventures, a division of Downing LLP, focuses on early to growth-stage technology companies. Their investment portfolio spans sectors including healthcare, clean technology, and software, with a preference for businesses that integrate sustainability and innovative solutions. Recent initiatives include the appointment of Dr. Nigel Pitchford as Head of Healthcare Ventures, reflecting their strategic focus on med-tech and life sciences. This division has supported over 20 healthcare companies, deploying more than £36 million since 2014. In addition to venture capital, Downing also invests in renewable energy projects, infrastructure, and property finance. They operate the Downing Renewables & Infrastructure Trust (DORE), which funds solar, wind, and energy storage projects across the UK and Northern Europe. Through these ventures, Downing aims to deliver stable returns while promoting environmental sustainability​.

DRADS Capital is a Boston-based venture capital firm focused on investing in groundbreaking innovations within the life sciences, biotechnology, and artificial intelligence sectors. The firm is driven by a mission to back visionary entrepreneurs who are pushing the boundaries of science and technology to create a healthier future. DRADS Capital targets early to late-stage companies that offer transformative solutions to some of the world's most challenging health problems. Founded by A. Nagarajan Pillay, a seasoned entrepreneur with over 25 years of experience, DRADS Capital has built a diverse portfolio that includes companies specializing in areas such as organ regeneration, precision fermentation, and AI-driven healthcare solutions. The firm is known for its hands-on approach, working closely with startups to navigate the complexities of bringing innovative healthcare products to market. DRADS Capital operates with a small, tight-knit team of experts who are deeply involved in every aspect of the investment process. This team includes professionals with backgrounds in law, venture capital, and global business development, all contributing to the firm's strategic vision.

Draper Associates, founded in 1985 by Tim Draper, is a renowned early-stage venture capital firm based in Silicon Valley. The firm has made significant investments in transformative companies across various sectors, including technology, consumer services, and financial services. Draper Associates is known for its notable investments in companies like Hotmail, Skype, Tesla, SpaceX, Twitch, Robinhood, Coinbase, and Baidu. The firm focuses on backing innovative startups with the potential for extraordinary outcomes, often investing at the seed stage and supporting companies through their growth journeys. Draper Associates prides itself on being entrepreneur-friendly, providing extensive support and resources to help founders succeed. Draper Associates is part of the larger Draper Ecosystem, which includes Draper University, Draper Venture Network, and Draper Startup House, among other initiatives aimed at fostering entrepreneurial growth and innovation globally. The firm's investment philosophy emphasizes a global perspective, investing in industry-transforming companies across the world while maintaining a strong presence in Silicon Valley. Draper Associates continues to innovate and drive significant impact in the venture capital landscape by backing visionary entrepreneurs and leveraging its extensive network and resources.

Draper B1, founded in 2010 and headquartered in Valencia, Spain, is a venture capital firm focusing on seed and early-stage investments. They emphasize supporting ambitious founders aiming to create impactful businesses. Draper B1 has a diverse portfolio spanning B2B, B2C, software, marketplaces, artificial intelligence, blockchain, and mobile applications. Notable investments include companies like Signaturit, Streamloots, and Erudit AI. They have supported over 150 companies, providing more than just capital. Draper B1 prides itself on hands-on investment and active portfolio management, leveraging a global network to help startups scale internationally. They have had multiple successful exits, including companies such as Jeff and Civitfun. Their team, led by Managing Partners like Luz Adell and Enrique Penichet Garcia, focuses on local sourcing for global scaling, helping startups navigate both local and international markets effectively. Draper B1 is part of the Draper Venture Network, enhancing their ability to support their portfolio companies with a broad range of resources and connections.

Dreamcraft Ventures, founded in 2019 and based in Copenhagen, Denmark, is an early-stage venture capital firm focused on investing in tech-driven startups across the Nordics and Europe. With a strong emphasis on industries like gaming, esports, B2B SaaS, digital entertainment, and fintech, Dreamcraft has developed a hands-on approach to supporting founders from seed to Series A. The firm refers to itself as "venture engineers," offering operational support and strategic guidance to help companies scale. Dreamcraft has a strong generalist investment strategy, reflected in its diverse portfolio that includes companies like Hiber, a social entertainment platform, and GRID, which leverages esports data assets. The firm raised €66 million for its second fund, Dreamcraft Fund II, and continues to actively invest in early-stage companies with a focus on helping them grow into category leaders. Founded by Jesper Søgaard and Christian Kirk Rasmussen, who built Better Collective into a billion-dollar company, Dreamcraft brings founder experience to the table, focusing on high-quality teams and long-term partnerships.

Dreamers VC, founded by Will Smith and Keisuke Honda, is a venture capital firm based in Los Angeles, focusing on early-stage investments across various sectors including health biotech, finance tech, consumer products, and entertainment. Since its inception, Dreamers VC has built a diverse portfolio of innovative companies. Their notable investments include Beam Therapeutics, which is pioneering precision genetic medicines; Nurx, providing personalized healthcare solutions delivered directly to consumers; and Sandbox VR, offering immersive group virtual reality experiences. Other significant investments include HomeCourt, a basketball training app, and Public, a platform for investing in crypto assets. Dreamers VC emphasizes community and leveraging their global network to connect founders with valuable resources. Their approach combines financial support with strategic guidance, ensuring startups have the tools they need to grow and succeed in competitive markets.

Dreamit Ventures is a leading venture capital firm that focuses on early-stage investments in Healthtech and Securetech startups. Founded in 2008, Dreamit has invested in over 350 companies, helping them scale revenues and achieve significant growth. Notable investments include SeatGeek, Redox, Eko, and Trendkite. Dreamit typically invests in companies that already have revenue or pilots, focusing on those ready to scale rapidly. The firm provides substantial support through its Customer Sprints® and Investor Sprints®, connecting founders with potential customers and investors. This approach helps startups gain traction and secure additional funding. Dreamit’s portfolio companies benefit from deep vertical expertise in cybersecurity, healthcare, and digital health, among other sectors. The firm is headquartered in New York and has a strong presence in the venture capital ecosystem, with a wide network of partners and advisors. Dreamit's investments are characterized by a focus on transformative technology and innovative solutions that address critical needs in their respective industries. For startups looking to engage with Dreamit, it is essential to demonstrate a clear path to revenue growth and scalability. The firm values strong, actionable business plans and provides ongoing support to help companies navigate the challenges of early-stage growth.

Drive Capital is a prominent venture capital firm based in Columbus, Ohio, founded in 2013 by Mark Kvamme and Chris Olsen, both of whom previously worked at Sequoia Capital. The firm focuses on investing in technology startups outside of Silicon Valley, with a particular emphasis on the Midwest, aiming to prove that world-class technology companies can emerge from any region in the United States. Drive Capital has raised over $2 billion to invest in startups solving significant problems in large markets. They have backed more than 80 companies, including notable investments like Duolingo, Root Insurance, Olive, Greenlight, and ApplyBoard. The firm is stage-agnostic, investing in seed, early-stage, and later-stage companies across various sectors such as healthcare, consumer services, information technology, and life sciences. The firm operates with a strong conviction in the potential of entrepreneurs from non-traditional tech hubs and emphasizes long-term partnerships. They seek out market-defining companies and prefer to journey with their portfolio companies from inception to IPO. Drive Capital's strategy is deeply rooted in leveraging local talent and resources, ensuring startups have the best advantages by building where they are strongest. Drive Capital's team includes a diverse group of investors committed to supporting founders with honesty and strategic guidance. They maintain a robust network and offer substantial resources to help startups navigate their growth trajectories. For entrepreneurs looking to engage with Drive Capital, the firm values bold, innovative ideas that address large market opportunities and demonstrate potential for significant impact​.

Droia Ventures is a Belgium-based venture capital firm that specializes in early-stage biotech investments, focusing exclusively on oncology and genetic diseases. With over €450 million under management, Droia supports young drug development companies that leverage cutting-edge science to bring breakthrough therapies to patients. Their portfolio includes companies such as Actio Biosciences and Vicinitas Therapeutics, which are focused on drug discovery in these high-impact areas. The firm’s investment strategy is highly targeted, aiming to fill the unmet medical needs in cancer treatment and genetic diseases like cystic fibrosis and hemophilia. Droia’s funds typically invest in newly founded or early-stage platform companies, often providing both financial backing and scientific expertise to help startups develop first-in-class drug candidates. Droia’s global reach is evident in its investments across the U.S. and Europe, with check sizes typically in the seed and early venture stages. Led by experienced partners like Janwillem Naesens and industry veteran George Golumbeski, Droia emphasizes long-term partnerships and active involvement in the scientific and business growth of its portfolio companies​.

DSM Venturing, the corporate venture arm of DSM, focuses on investing in innovative startups that align with its mission of improving health, nutrition, and bioscience. Since its inception in 2001, DSM Venturing has invested in over 100 startups across these sectors. Their portfolio includes companies such as NutriLeads, which develops food ingredients with health benefits, and Deep Branch Biotechnology, which converts carbon dioxide into sustainable animal nutrition products. Geographically, DSM Venturing is particularly active in North America and Europe. They typically invest between €1 million and €20 million over the lifetime of a venture, starting with initial investments ranging from €100k to €5 million. They take minority ownership stakes and often lead investment rounds while actively participating in the board activities of their portfolio companies​. DSM Venturing's investment strategy focuses on startups that offer transformative solutions in health, nutrition, and care, as well as animal nutrition and health, and food innovation. They aim to support these companies not only with funding but also with access to DSM's extensive scientific and commercial resources, fostering innovations that have the potential to make significant societal impacts​.

Dundee Venture Capital, founded in 2010 and based in Omaha, Nebraska, focuses on early-stage investments in high-growth technology companies. The firm is known for its hands-on approach and leadership in seed rounds, frequently leading 90% of their investments. Dundee VC invests predominantly in e-commerce, fintech, and SaaS, with notable portfolio companies including Summersalt, a direct-to-consumer lifestyle brand, and Omnia Fishing, an e-commerce platform for anglers. Their recent investments include Nyla, a no-code platform for e-commerce, and Pear Commerce, which aids grocery retailers with digital marketing. Dundee Venture Capital’s strategy emphasizes funding transformative startups located outside traditional coastal hubs. They seek companies with a strong vision, early traction, and a unique edge. With a commitment to seed-stage investing, Dundee is particularly interested in businesses that have potential for significant impact and rapid growth. The firm prefers to engage with founders who have a clear and compelling vision and are tackling urgent and valuable problems. The team, led by founder Mark Hasebroock, brings deep entrepreneurial experience and a track record of success, including the sale of Hayneedle to Walmart. Startups should approach Dundee with a robust business plan that demonstrates significant potential and a differentiated market approach.

Dutch Founders Fund (DFF) is an Amsterdam-based early-stage venture capital fund established by a group of successful Dutch entrepreneurs, including Laurens Groenendijk (Just Eat, Treatwell, Miinto), Patrick Kerssemakers (fonQ), Bas Beerens (WeTransfer), Hidde Hoogcarspel (Spacebuzz), and Remco van Zanten (ex-Booking.com, Zalando). The fund focuses on investing in marketplaces, network effects-driven propositions, and marketplace enablers across Europe. Notable investments by DFF include VonWood, which revolutionizes the wood industry with a transparent supply chain solution; Kennek, a SaaS-enabled marketplace for the alternative credit space; and Metycle, a global marketplace for scrap and recycled metal. Another significant investment is Mtor, an automotive parts marketplace in Egypt, addressing logistics and price transparency challenges. Additionally, HomeCooks, a foodtech platform in the UK, allows home chefs to sell their homemade dishes to a wider audience. DFF's investment strategy emphasizes providing intense mentoring from ideation to Series A, seeking companies that offer sustainable solutions and efficiency. They value founders who are ambitious, coachable, and ready to face challenges head-on. The fund is committed to simplicity, transparency, and equal distribution, ensuring every stakeholder gets a fair share of the value created. The team, with extensive experience and a strong track record in building successful companies, offers more than just capital. They dive deep into the operational aspects of their portfolio companies, providing hands-on support to help them grow and succeed.

Dynamk Capital is a New York-based venture capital firm that specializes in investing in early-stage companies within the life sciences sector, particularly focusing on life science industrials. Established in 2016, Dynamk Capital targets startups that develop critical tools, technologies, and services essential for the discovery, development, and manufacturing of life-saving therapies. The firm plays a pivotal role in advancing innovative solutions across the biopharma continuum, from drug discovery to development and production. Dynamk Capital's investment strategy is centered around providing both capital and strategic support to early-stage companies, helping them scale and succeed in a highly competitive and complex industry. The firm's portfolio includes a diverse range of companies, such as RoosterBio, which specializes in cell and exosome manufacturing, and Virica Biotech, which focuses on enhancing viral vector manufacturing for gene therapy. These investments reflect Dynamk's commitment to driving innovation in biomanufacturing and life sciences. The firm recently closed its inaugural life sciences fund at $65 million, marking a significant milestone in its mission to support groundbreaking life science ventures. Dynamk Capital continues to be an active player in the venture capital space, leveraging its industry expertise to identify and nurture companies that have the potential to make substantial contributions to healthcare and biopharmaceutical advancements.

Dynamo Ventures, established in 2016 and headquartered in Chattanooga, Tennessee, is a seed-stage venture capital firm that focuses on supply chain and mobility technology. The firm is known for investing in startups that address critical issues in the logistics, transportation, and supply chain sectors. Dynamo Ventures typically invests between $250,000 and $1.2 million per seed-stage company. Their notable portfolio includes Sennder, a German digital freight brokerage that recently achieved unicorn status with a valuation of $1.45 billion. Other significant investments are STORD, a digital warehouse and distribution network based in Atlanta, and Shipamax, a digital platform for bulk shipping. Additionally, they have backed companies like Skupos, a data analytics platform for convenience stores, and Celadyne Technologies, which focuses on advanced materials for batteries. Dynamo's investment strategy is centered around providing not only capital but also extensive industry expertise and network connections to help their portfolio companies succeed. The firm recently raised $43.21 million for their second fund, more than doubling the size of their first fund, which indicates strong investor confidence in their focused approach.

Eagle Venture Fund is a venture capital firm based in Fort Worth, Texas, with additional offices in Zurich and Singapore. Founded with a mission to drive both financial returns and significant social impact, Eagle Venture Fund focuses on early-stage investments in startups that tackle major societal challenges such as human trafficking, poverty, and healthcare for underserved populations. The firm operates several funds, including the Eagle Venture Fund IV, Eagle Freedom Fund, and Eagle City Fund. These funds support companies that are not only profitable but also dedicated to creating sustainable and exponential impacts. For example, the Eagle Freedom Fund specifically targets initiatives combating modern slavery and human trafficking. Eagle's investment approach is deeply integrated with their Venture Builder Engine, which provides startups with extensive support in areas such as strategic counsel and founder development. This hands-on approach helps portfolio companies scale effectively while staying true to their mission-driven goals. The leadership team at Eagle includes experienced professionals like Wes Lyons and Wade Myers, who bring a wealth of experience in both venture capital and impact investing. The firm has built a strong reputation for backing bold entrepreneurs who are passionate about creating change in areas where it’s most needed​.

Earlybird Venture Capital, founded in 1997, is a leading European venture capital firm with a strong focus on technology innovators. They manage around €2 billion in assets and have invested in over 220 companies across various sectors including digital technologies, healthcare, and deep tech. Earlybird operates four specialized funds: Digital West, Digital East, Health, and Earlybird-X, each targeting different geographies and technological areas. Notable investments include UiPath, a global leader in robotic process automation, and N26, a mobile banking platform. Earlybird has achieved significant exits through IPOs and trade sales, contributing to its reputation as one of Europe’s most experienced venture investors. Earlybird's strategy involves not only providing financial resources but also strategic support and access to an international network, aiding portfolio companies in scaling and succeeding in global markets. The firm is committed to sustainable practices and expects the same from its portfolio companies. For startups looking to engage with Earlybird, demonstrating innovative technology and scalability, particularly within Europe, can increase the likelihood of securing investment. The firm’s hands-on approach and extensive network provide substantial support to their portfolio companies, fostering growth and market success.

East Ventures is one of Southeast Asia's most active venture capital firms, known for backing some of the region's most successful startups. With investments in Tokopedia, Traveloka, Xendit, and Carro, it has a strong track record of nurturing unicorns. The firm primarily focuses on sectors like fintech, healthcare, SaaS, and logistics, with an emphasis on Indonesia, where it helps drive digital and economic growth. Recent investments include AWST (Web3), McEasy (telematics), and Rekosistem (waste management), reflecting its broad sectoral interest. East Ventures typically invests at the seed stage but also participates in growth rounds through its EV Growth Fund. It operates across multiple locations, including Jakarta, Singapore, and Japan, and is deeply committed to sustainability, with goals like achieving net-zero emissions by 2050. The firm supports ESG initiatives across its portfolio and actively engages in environmental projects such as mangrove reforestation. Co-founded by Willson Cuaca, Roderick Purwana, and Melisa Irene, East Ventures is recognized globally, having been ranked among the most active VCs by Pitchbook and CB Insights. The firm maintains a founder-centric philosophy, investing in people and markets over products, which has been key to its long-term success.

Eastlink Capital, founded in 2014 and headquartered in Menlo Park, California, is a venture capital firm focused on early and growth-stage investments in enterprise software, cloud infrastructure, AI, and data-driven technologies. Led by Steven Xi, the firm specializes in identifying high-potential startups that leverage unique technologies to solve critical problems in large markets. Their approach is deeply technical, often helping portfolio companies refine their product strategies and expand into new markets. Eastlink’s investment strategy is centered on mission-driven founders and innovative technologies, particularly in the AI, cloud-native, and data infrastructure sectors. Some of their prominent investments include StreamNative, TigerGraph, and MotherDuck, showcasing their commitment to supporting companies that build foundational enterprise technologies. What sets Eastlink apart is their cross-border expertise and a strong network, which they use to help their portfolio companies scale globally. Beyond providing capital, the team is known for being hands-on, offering strategic advice and connecting startups with key industry executives and partners. Eastlink has a track record of successful exits, including companies like Evernote and Sensely. The firm’s leadership team includes experienced investors like Eric Ye, who brings a wealth of knowledge in cloud-native infrastructure, and other seasoned advisors who provide deep technical insights and guidance to the companies they back. Eastlink Capital is well-positioned to support startups aiming to disrupt enterprise markets with groundbreaking technologies.

Eastward Capital Partners is a venture debt and equity financing firm specializing in technology-enabled businesses. With a portfolio of over 160 companies across sectors like SaaS, health technology, and B2B services, they offer non-dilutive capital that helps startups extend their cash runway without sacrificing equity. Notable investments include companies such as GoSecure, Lightmatter, and Survios. Eastward typically partners with leading venture capital firms, favoring innovative firms in high-growth sectors like cybersecurity, enterprise software, and e-commerce solutions. Geographically, they focus on U.S.-based companies, with a preference for those in the Northeastern region. Their strategy emphasizes flexible financing structures that avoid restrictive covenants, making them an attractive choice for scaling startups. They also tend to co-invest alongside established VCs, complementing equity funding rounds with venture debt to optimize the company's capital structure. Led by Dennis Cameron, with nearly four decades of experience in structured finance and venture debt, Eastward Capital brings deep expertise to its partnerships. Startups seeking funding can benefit from their extensive industry knowledge and active involvement in structuring deals that align with business goals.

Eclipse Ventures, founded in 2015 and headquartered in Palo Alto, California, is a venture capital firm that focuses on transforming essential industries through innovative technology. The firm has over $2 billion in assets under management and invests in sectors such as manufacturing, logistics, supply chain, energy, healthcare, and transportation. Notable investments in their portfolio include VulcanForms, which develops advanced digital manufacturing infrastructure; Augury, providing machine health insights; Enovix, designing advanced lithium-ion batteries; and Cellares, which offers scalable cell therapy manufacturing solutions. Eclipse Ventures has made over 108 investments and has seen 11 successful exits, including companies like Light and Veev. The firm typically invests across various stages, from pre-seed to Series D, and aims to modernize physical industries that are critical to the economy. Their team is composed of experienced operators and investors who provide strategic support and resources to help portfolio companies grow and succeed.

Educapital is a leading European venture capital firm founded in 2017, dedicated to investing in the Edtech and Future of Work sectors. Based in Paris, France, Educapital focuses on supporting innovative companies that aim to transform education and the workplace through technology. The firm was co-founded by Marie-Christine Levet and Litzie Maarek, marking it as the first independent VC firm in Europe founded by women. With $200 million in assets under management, Educapital is the largest European fund in its niche, investing in startups from late seed to Series B stages with check sizes ranging from €3 million to €10 million. Their portfolio includes over 30 companies that are making significant impacts in education and the future of work, such as an online school for entrepreneurship, a collaborative learning management system, and platforms for immersive science learning and career guidance. Educapital’s investment thesis revolves around backing mission-driven entrepreneurs with strong leadership, focusing on companies that have the potential to become global leaders and contribute to building a sustainable society. The firm’s impact-driven approach ensures that their investments not only generate financial returns but also drive significant positive changes in the educational landscape.

eHealth Ventures, founded in 2014, is a digital health-focused venture capital firm based in Israel. It primarily invests in early-stage startups, focusing on innovative technologies that drive the transition from hospital care to home care and predictive healthcare solutions. With over $70 million in assets under management, the firm operates a unique investment structure, providing both capital and extensive support to its portfolio companies. Their investments target pre-seed to early-stage rounds, often leveraging non-dilutive funding from the Israeli Innovation Authority. eHealth Ventures boasts a diverse portfolio of over 30 startups, including companies like AccuLine, which is developing a non-invasive heart attack detection test, and GaitBetter, an AI-driven platform for fall prevention and rehabilitation. The firm’s strategic partnerships with healthcare heavyweights such as Maccabi Healthcare Services, Amgen Ventures, and the Mayo Clinic allow its portfolio companies access to vast medical networks and commercial opportunities across the globe. Led by CEO Talor Sax, eHealth Ventures plays a pivotal role in nurturing digital health startups, providing hands-on guidance from the early stages through to commercialization. The firm’s mission is to address pressing healthcare challenges by investing in solutions that improve accessibility, reduce costs, and enhance patient care. Its approach is deeply rooted in collaboration, bringing together industry leaders, healthcare providers, and technologists to shape the future of digital health.

Eight Roads Ventures, founded in 1969, is a global venture capital firm and the corporate investment arm of Fidelity International. The firm manages over $11 billion in assets and has a significant presence in major markets including the UK, China, India, Japan, and the US. Eight Roads focuses on investing in technology and healthcare sectors, backing companies from early to growth stages. Eight Roads has built an impressive portfolio with over 300 active companies and 19 unicorns, including notable names like AppsFlyer, Icertis, and Akulaku. The firm is also known for its strong support network, providing not just capital but also strategic guidance and resources to help its portfolio companies scale globally. The firm recently launched a $375 million fund focused on Europe and Israel, targeting sectors such as enterprise technology, consumer, fintech, and healthcare IT. This fund aims to make 15 to 20 investments of $10 million to $30 million each​. Eight Roads' team includes seasoned professionals like Daniel Auerbach, Senior Managing Partner & Head of Global Ventures, and Jarlon Tsang, Managing Partner & Head of China, who bring extensive experience and expertise to the firm's operations.

Eka Ventures is a London-based venture capital firm founded in 2018 by Camilla Dolan, Jon Coker, and Andrew Richardson. The firm is dedicated to investing in early-stage startups that aim to create a positive system change, focusing on companies that promote sustainability, health, and inclusivity. Eka Ventures primarily invests in the seed and Series A stages, with typical check sizes ranging from £0.5 million to £3 million. The firm’s portfolio includes a diverse range of companies, such as Byway, a sustainable travel platform, and Hived, a green logistics startup. Eka Ventures is particularly interested in technology-driven businesses that leverage data and science to build solutions that can scale and make a significant impact on the economy and environment. Eka’s strategy revolves around partnering with mission-driven founders who are building category-defining technology companies. The firm is known for its hands-on approach, working closely with founders to support their growth and scale their businesses. With all of its team members based in London, the firm emphasizes a collaborative and supportive environment, providing not only capital but also strategic guidance and operational support. For startups seeking investment, Eka Ventures values a clear mission-driven approach that aligns with their focus on sustainability and positive impact. The firm’s founders have a strong background in consumer technology and a deep commitment to backing companies that aim to solve critical global challenges.

Elaia Partners is a leading European venture capital firm focused on investing in digital and deep tech startups from early-stage to growth development. Founded in 2002 and headquartered in Paris, Elaia manages over €700 million in assets. The firm has built a strong reputation for backing ambitious tech entrepreneurs, with notable investments in companies like Mirakl, Shift Technology, Ornikar, and iBanFirst. Elaia's investment strategy emphasizes supporting disruptive technologies and innovative business models across various sectors, including SaaS, AI, fintech, and health tech. They typically invest in early-stage companies with high growth potential, providing both capital and strategic guidance to help these startups scale globally. Their portfolio includes over 100 investments and 80 successful exits, showcasing their ability to identify and nurture high-potential startups. The firm is known for its close relationships with deep tech academia and its commitment to ESG principles. Elaia's team consists of experienced investors and entrepreneurs who work closely with portfolio companies to drive growth and achieve long-term success. The firm's recent launch of the Elaia Delta Fund, which secured €115 million in its initial closing, underscores their ongoing commitment to supporting tech disruptors.

Elementum Ventures, founded in 2014 and based in Menlo Park, California, is a venture capital firm that focuses on investing in seed-stage deep technology companies. The firm targets large markets with intellectual property as their primary differentiation and defensibility, emphasizing emerging technologies that are on the cusp of commercialization. They provide not only capital but also strategic support through their network of strategic partners, advisors, and potential customers. Elementum Ventures has a notable portfolio that includes companies like Anduril, a defense technology company, and Fathom Radiant, which works on advanced AI hardware. They also invest in diverse sectors such as consumer products, virtual reality, augmented reality, artificial intelligence, and machine learning. The firm's team includes General Partners Ben Chelf, Ben Patterson, and Kurt Keilhacker. Ben Chelf co-founded Coverity, which was later acquired by Synopsys. Ben Patterson has a background in music and IT infrastructure, while Kurt Keilhacker has co-founded and invested in over 50 companies across the US and Europe. For startups looking to engage with Elementum Ventures, demonstrating strong intellectual property and the potential for significant market impact can be advantageous. The firm's deep involvement and extensive network support can provide significant value to early-stage ventures​.

Elevat3 Capital is the venture capital arm of Christian Angermayer's Apeiron Investment Group, a global investment firm with over $2.5 billion in assets under management. Elevat3 focuses on investing in high-growth technology companies across Europe, often leading or co-leading rounds with ticket sizes ranging from $5 million to $20 million. The firm targets industries undergoing significant change, particularly in sectors like life sciences, fintech, and future technologies. The team at Elevat3 is known for its hands-on approach, providing strategic support beyond just capital to help portfolio companies scale effectively. With a presence in key locations like Berlin, London, and New York, Elevat3 leverages a robust network and deep industry expertise to drive value creation in its investments. Some of the notable investments include Gropyus, a company focused on sustainable building technologies, and Formo, which is pioneering the production of cultured dairy products. The firm’s investment strategy emphasizes finding and activating key "triggers" that can significantly elevate a company’s valuation and market position.

Elevate Capital is a pioneering venture capital fund with a mission to support underserved entrepreneurs, including women, minorities, veterans, and those with limited regional access to capital. Since its launch in 2016, Elevate has made significant investments in diverse founders across various industries such as healthcare, fintech, cybersecurity, and SaaS. Notable investments include startups like Troy Medicare and Blendoor. Focusing on pre-seed to Series A stages, Elevate typically invests between $25k to $2 million. Their strategic emphasis is on scalable startups founded by underrepresented groups, aiming to foster generational wealth and economic impact. They primarily target companies in Oregon through the Innovation Gap Fund, but their Capital Fund II extends investments nationally. The fund's approach is deeply rooted in active mentorship and hands-on support, leveraging the extensive experience of its team members. Key figures include Managing Partner Nitin Rai, who is instrumental in guiding the fund's inclusive investment strategy. Other notable team members are Lateef Jackson, focusing on healthcare technology, and Giovanni, who brings expertise in global strategy and market development. Elevate Capital's proactive outreach and strategic networking are key elements in building their investment funnel. Entrepreneurs are encouraged to approach them via warm introductions or direct contact through their website. By prioritizing diversity and inclusion, Elevate Capital stands out in the venture capital landscape, driving meaningful change and supporting the next generation of visionary founders.

Elizabeth Street Ventures is an early-stage venture capital firm based in New York, specializing in the digital consumer space. Founded in 2018, the firm focuses on businesses that are transforming how people shop, interact, and live by funding category-defining products and services. Their investments target sectors like digital commerce, consumer fintech, and health and wellness, with a strong emphasis on enhancing the customer experience. The firm typically participates in seed and pre-seed rounds, with average check sizes ranging between $500K and $750K. Notable portfolio companies include Rise Brewing Co., Oros, and SimpliFed, showcasing their interest in innovative consumer brands that push boundaries in sustainability, wellness, and technology. Elizabeth Street Ventures often co-invests with other top-tier investors, leveraging their vast network to help portfolio companies scale effectively. Led by co-founders Will McClelland and Ben Sontheimer, the firm prides itself on being highly selective, focusing on building long-term relationships with founders who are passionate about reimagining consumer experiences. They follow a hands-on approach, providing strategic guidance, operational support, and key industry connections to help companies grow. The team’s diverse expertise, ranging from consumer retail to financial technology, positions Elizabeth Street Ventures as a trusted partner for early-stage entrepreneurs aiming to disrupt traditional industries and create market-leading brands.

Embark Ventures, based in Santa Monica, California, is a venture capital firm specializing in pre-seed and seed-stage investments. Founded in 2017 by Peter Lee and Yipeng Zhao, the firm focuses on "deep tech" companies that possess proprietary technology offering a significant competitive advantage in transforming multi-billion dollar industries. The sectors they target include bio-healthcare, software and computing, manufacturing and industrial, material science, robotics and automation, and sensors and semiconductors​. Embark Ventures has made numerous notable investments, including companies like Truvian Sciences, Parallel Systems, Kula Bio, and Machina Labs. Their strategy involves backing ambitious teams with breakthrough technologies that can disrupt large markets. The firm typically invests between $100,000 and $2 million in their portfolio companies​.

Emerald Technology Ventures, founded in 2000, is a prominent venture capital firm based in Zurich, Switzerland, with offices in Toronto and Singapore. The firm specializes in investments in clean technology, targeting sectors such as energy, water, wastewater, materials, packaging, mobility, urbanization, food, and agriculture. With assets under management exceeding €1 billion, Emerald has made significant contributions to the advancement of sustainable technologies. Emerald's portfolio includes a variety of innovative companies. Notable investments include SewerAI, a leader in AI and cloud-driven sewer condition assessment, and SpotLight, which develops non-invasive subsurface surveillance solutions for carbon dioxide geological storage. Other significant investments are in companies like Kalpana Systems and VYTAL, which focus on semiconductor technology and reusable packaging solutions, respectively. The firm has also achieved successful exits with companies such as Rhombus Energy Solutions, DeepSea Technologies, and Spear Power Systems, showcasing its ability to nurture and scale startups towards successful outcomes. Emerald's investment strategy is driven by a commitment to tackling major challenges in climate change and sustainability, leveraging their expertise and extensive network to support groundbreaking innovations in these fields. Emerald's team comprises experienced professionals, including Hans Dellenbach, Markus Moor, and Christoph Frei, who bring a wealth of knowledge and strategic insight to their portfolio companies. Their approach combines financial investment with strategic support, ensuring that their portfolio companies can thrive and make a substantial impact on their respective industries.

Emerge Education, founded in 2013 by Jan Lynn-Matern, is a London-based venture capital firm that specializes in early-stage investments in educational technology companies. The firm’s mission is to democratize access to opportunity by being a catalytic partner for early-stage edtech founders. Emerge Education focuses on sectors such as higher education, lifelong learning, and the future of work, investing primarily in pre-seed and seed stages across Europe and North America. Emerge Education is distinguished by its backing from over 100 of the world's leading edtech operators, offering founders unparalleled insights and support from industry experts. Their typical investment ranges from £250,000 to £1.5 million, and they provide hands-on support to help startups scale and succeed. Notable investments in their portfolio include companies like Tomorrow University of Applied Sciences, Causaly, Unibuddy, and Mentor Collective, which are driving innovation in various aspects of education and workforce development​ (Emerge Education)​​ (PitchBook)​. Emerge Education has also seen successful exits, such as Zavvy and Kide Science, showcasing their effective investment strategy and support mechanisms. For startups looking to partner with Emerge Education, demonstrating strong alignment with their focus on transformative education technologies and a clear ambition to become global category leaders is key.

Emergence Capital Partners Limited is a full-fledged financial services company specializing in fixed income brokerage and business and financial advisory services. Based in Africa, the firm engages in trading treasury bills, corporate bonds, and government bonds, offering clients opportunities for stable, fixed returns on mid to long-term investments. The firm also provides bespoke, one-on-one financial advisory services, tailored to meet the unique needs of its clients, from retail investors to high-net-worth individuals and institutions. Founded with the mission to drive high-growth potential and sustainable businesses, Emergence Capital partners with early-stage companies and founding teams across Africa. The firm is often among the first to invest, using a variety of strategies and instruments that are best suited to the markets in which they operate. Their advisory services are comprehensive, helping companies navigate financial challenges and achieve their business objectives. The team at Emergence Capital is comprised of experienced professionals with extensive backgrounds across various sectors, leveraging their expertise to deliver superior value and outcomes for their clients.

Emerson Collective, founded by Laurene Powell Jobs, is a unique blend of philanthropy and impact investing focused on education, immigration, the environment, media, and health. Notable investments include AltSchool, College Track, and XQ Institute, emphasizing their commitment to transforming education and creating social impact. They invest globally but have a strong presence in the US. Their strategy involves partnering with innovative entrepreneurs and providing not just capital but also strategic support to scale impactful solutions. The team is composed of experts from various fields, ensuring a comprehensive approach to addressing complex social issues.

Emles Venture Partners, founded by seasoned entrepreneurs with successful exits, offers a dynamic approach to venture capital investment. Known for their swift decision-making, Emles provides investment verdicts within 72 hours, ensuring startups can maintain momentum. The firm is distinguished by its diverse portfolio, with 45% of founders being female or from diverse backgrounds, and 55% being international. Emles invests across various industries without sector or geographic constraints, focusing on seed-stage companies and supporting them through their growth stages with follow-on investments in 75% of cases. Notable investments include 1910 Genetics, Shiru, Zeta Surgical, and Arist, each recognized for innovative contributions in their respective fields. Key team members include Gabriel Hammond, a partner with significant experience and two company exits, Emanuel Zareh, and Rachel Deinhart, specializing in venture debt. Emles emphasizes personal capital investment, having committed $25 million to empower founders. Their strategic approach involves offering bridge capital and unique debt offerings to optimize the cost of capital, maximizing founders' equity. Emles is celebrated for its lack of bureaucratic constraints, focusing solely on the best ideas, and supporting founders with operational guidance and strategic insight. Founders praise the firm for its unwavering support and commitment through multiple funding rounds, making Emles a preferred partner for ambitious startups.

Empath Ventures is a venture capital firm founded in 2021 in Los Angeles, California, focused on psychedelic medicine and exponential health technologies. The firm's investment philosophy is grounded in scientific rigor applied to modern medicine, combining emerging pharmaceutical research with exponential technologies and transdisciplinary collaboration. Its thesis is built around three goals: healing the sick, preventing illness, and enhancing human health through novel therapeutic approaches. The firm has made 4 investments at Seed and Series A stages, with check sizes in the $100,000 to $2 million range. Notable portfolio companies include Psylo, a psychedelic medicine company, and Motif Neurotech, a neuro-technology firm. The team consists of six people including three partners. The firm has since rebranded to Focalpoint Partners and is also listed under the name XEIA Venture Partners on some platforms. Empath Ventures represents an emerging category of specialized healthcare venture capital focused on the psychedelics-as-medicine sector, a field that has attracted growing scientific and regulatory interest. The firm positioned itself at the convergence of biotechnology, pharmaceutical research, and health technology, backing founders working at the earliest and most scientifically uncertain stages of therapeutic development where access to patient, knowledgeable capital is most scarce.

Empede Capital is a venture capital firm established in 2021, with a focus on disruptive technologies across various sectors. Headquartered in Tortola, British Virgin Islands, with additional offices in the UAE and the UK, Empede Capital primarily invests in Seed to Series B startups. The firm’s expertise spans industries like cyber technology, construction technology, healthcare, agriculture, fintech, cloud, virtual reality, drone technology, and more. Empede Capital emphasizes innovation and scalability, investing in companies that leverage emerging technologies to disrupt traditional industries. Some of its notable portfolio investments include Instacart, Better.com, Digital Ocean, and Axiom Space. The firm's founding partners, including Mukund Hirani, Prakash Senghani, Raj Varsani, and Dinesh Dabasia, bring extensive experience from sectors like cyber, real estate, and construction, which they use to provide both financial support and strategic guidance to the startups they back. Empede Capital's approach focuses on providing "smart capital," leveraging its domain expertise to help companies scale and achieve industry disruption.

Enauto Ventures is a California-based venture capital fund founded in 2018 in Los Angeles, focused on AI and data-driven investments in life sciences, healthcare, and human behavior. The firm backs businesses that improve the daily human experience through artificial intelligence, with sector concentrations in medical diagnostics, therapeutics, health IT, biotech, medical devices, and pharmaceuticals. Co-founded by Alexandre Perrin and led by Managing Partner Eirini Schlosser, the firm deployed checks of $1 million to $8 million with a sweet spot of $3 million at Seed and Series A stages. Enauto made 9 investments across healthtech, AI and deep tech, biotech, and pharma, targeting companies using data and machine learning to advance clinical and commercial outcomes. The firm supported founders with deep operational, strategic, and technological guidance and facilitated global expansion through a network of executives, veteran investors, and seasoned entrepreneurs across international markets. Enauto Ventures is listed as inactive. During its operational period the firm represented a focused effort to connect advanced AI methodology with life sciences applications, a thesis that has since gained significant mainstream venture attention. The founders' backgrounds in technology and life sciences gave the firm a differentiated perspective on companies operating at the intersection of data science, diagnostics, and therapeutic innovation.

Endeit Capital is a venture capital firm based in Amsterdam, with additional offices in Hamburg and Stockholm. Since its inception in 2006, Endeit Capital has been a driving force in scaling European tech companies, focusing on digital media, SaaS, and e-commerce. Their notable portfolio includes investments in Lepaya, a B2B training platform, and successful exits like 3D Hubs, acquired by Protolabs for $330 million, and neo-broker BUX. Endeit primarily invests in later-stage startups, providing growth capital typically between €7 million and €15 million. Their strategy emphasizes fueling internationalization and innovation, preferring companies with strong market potential and scalable business models. They usually lead funding rounds, demonstrating a hands-on approach in their partnerships. Endeit Capital's investment activities are geographically centered in Europe, with a significant focus on the Benelux region and Germany. They have a robust network, collaborating with 72 entrepreneurs and several co-investors. The team at Endeit Capital is composed of seasoned professionals like co-founders Hubert Deitmers and Joop van den Ende, both based in Amsterdam. Key partners include Martijn Hamann and Ilan Goudsmit, who bring extensive experience in software, marketplaces, and mobile industries. For startups seeking investment, Endeit Capital values a clear demonstration of cultural fit and mission-driven goals. They build their funnel through proactive deal flow generation and maintaining strong industry connections, making them a preferred partner for ambitious tech scale-ups looking to expand their footprint in Europe.

Endiya Partners, founded in 2015 and based in Hyderabad, India, is an early-stage venture capital firm focusing on deep tech, healthcare, and enterprise technology. The firm is known for its significant contributions to the startup ecosystem, particularly in supporting innovative and scalable businesses. Endiya's portfolio includes a variety of notable investments. For instance, Darwinbox, a comprehensive HR management platform; Kissht, a consumer credit platform; and Cult.fit, a health and wellness company. Additionally, their investments in the healthcare sector include SigTuple, which utilizes AI for medical diagnostics, and EKincare, a health benefits platform offering preventive and personalized healthcare services. The firm has seen successful exits such as ShieldSquare, acquired by Radware, and Steradian Semiconductors, acquired by Renesas. Endiya Partners has been actively deploying its second fund, which closed at $75 million in 2021, to continue supporting promising startups. Key team members include co-founders Sateesh Andra, Ramesh Byrapaneni, and Abhishek Srivastava, who bring extensive industry experience and a strong network to help their portfolio companies grow and succeed.